Merry Christmas and a Happy New Year 2025
The year is drawing to a close – time to say thank you to my readers who regularly follow this blog and enrich it with their suggestions and comments. And time to look at the
Continue reading
Tag: MS Therapy
The Epstein-Barr Virus (EBV) – Facts and Considerations Regarding Vaccination (3)
The Epstein-Barr virus (EBV) persists for life in the human body after a primary infection. Most often, the infection has no consequences, but the virus can also cause severe illness and is associated with the
Continue reading
CAR-T Cell Therapy and Multiple Sclerosis – Current Status
Prof. Mathias Mäurer discusses in this video about the new form of therapy and the current status of results on CAR-T cell therapy for MS. Please consider using the automated translation of YouTube. You can
Continue reading The Epstein-Barr Virus (EBV) – Facts and Considerations on Infection (2)
The Epstein-Barr virus (EBV) belongs to the family of herpes viruses. EBV was first identified as a human tumor virus in Burkitt’s lymphoma (an aggressive blood cancer of the B-cell series) and has subsequently been
Continue reading The Epstein-Barr Virus (EBV) – Facts and Considerations (1)
The Epstein-Barr virus, or EBV for short, often causes confusion in connection with multiple sclerosis. Therefore, this is the start of the first of three parts with facts and considerations about EBV and MS. In
Continue reading
Update Radiologically Isolated Syndrome (RIS)
Radiologically isolated syndrome (RIS) refers to an incidental finding in magnetic resonance imaging (MRI) where lesions typical of multiple sclerosis (MS) are found, even though the MRI was not performed under clinical suspicion of MS,
Continue reading
Side Effect of MS Medications: Ocrelizumab
Ocrelizumab (Ocrevus®) is a monoclonal antibody and belongs to the group of so-called B-cell-depleting therapies, which currently play a very important role in the immunotherapy of Multiple Sclerosis. They are used quite frequently. This article
Continue reading
High-Dose Biotin is a Dead End
The treatment options for progressive MS are limited – so interest was high when the study data on the use of high-dose biotin in progressive MS was first presented at the American Neurology Congress in
Continue reading
Immunity Against Viral Infections – Adaptive Immunity
The immune defense against microorganisms is carried out with the help of two lines of defense – the first line of defense, the so-called innate immunity (innate immunity) reacts quickly but unspecifically and is mediated
Continue reading Approval of Siponimod in the USA and Europe – the vote of the regulatory authorities
The new MS drug Siponimod, the further development of Fingolimod (Gilenya®), was recently approved by the Food and Drug Administration (FDA) in the USA and has been available there for some time for MS patients
Continue reading
